Safe Orthopaedics S.A.
ALSAF.PA · PAR
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | €5,810 | €5,861 | €4,554 | €3,658 |
| % Growth | -0.9% | 28.7% | 24.5% | – |
| Cost of Goods Sold | €1,487 | €10,219 | €1,980 | €2,259 |
| Gross Profit | €4,323 | -€4,358 | -€5,740 | -€5,052 |
| % Margin | 74.4% | -74.4% | -126% | -138.1% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €227 | €202 | €9,201 | €7,486 |
| SG&A Expenses | €262 | €307 | €9,267 | €7,524 |
| Sales & Mktg Exp. | €35 | €105 | €66 | €38 |
| Other Operating Expenses | €12,039 | €8,149 | €8,344 | €6,450 |
| Operating Expenses | €12,301 | €9,889 | €10,163 | €8,091 |
| Operating Income | -€7,978 | -€5,962 | -€7,582 | -€6,668 |
| % Margin | -137.3% | -101.7% | -166.5% | -182.3% |
| Other Income/Exp. Net | -€263,338 | -€1,002 | €873 | -€1,638 |
| Pre-Tax Income | -€271,316 | -€6,964 | -€6,709 | -€8,306 |
| Tax Expense | -€65,872 | €1 | €1 | -€2 |
| Net Income | -€205,444 | -€6,965 | -€6,709 | -€8,306 |
| % Margin | -3,536% | -118.8% | -147.3% | -227.1% |
| EPS | -2,706,764 | -96,154 | -92,620 | -227,853,436 |
| % Growth | -2,715% | -3.8% | 100% | – |
| EPS Diluted | -2,348,260 | -56,972 | -54,878 | -227,853,436 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | -€263,498 | €0 | €0 | €0 |
| Interest Expense | €218 | €355 | €638 | €861 |
| Depreciation & Amortization | €2,875 | €985 | €866 | €568 |
| EBITDA | -€268,171 | -€5,624 | -€5,201 | -€6,879 |
| % Margin | -4,615.7% | -96% | -114.2% | -188.1% |